A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH
Recruiting
N/A
Interventional Study
Dentin Sensitivity
Hypersensitivity
Cervical Lesion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 25 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 120 (estimated)
- Sponsor
- Dow University of Health Sciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other dental defects". DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages. The use of laser has opened new dimensions in the treatment of DH. To the author's knowledge, not much…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* Patients of either gender, with ages between 25-65 years
* should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration
Exclusion criteria:
* History of desensitizing therapy on the affected tooth/teeth in last six mon…
Contacts